AME Logo
VC

Valentina Cambiano

PhD

Institute for Global Health, University College London, United Kingdom

Biography

Valentina Cambiano is an Associate Professor in Epidemiology in the Institute for Global Health at University College London. She is deeply interested in addressing research questions of public health importance related mainly to HIV. In particular, she models HIV epidemics to investigate the impact and value of different HIV testing modalities and prevention tools, including evaluating their cost-effectiveness and collects and analyses observational data.

Currently, she holds a UKRI Future Leader Fellowship, working in partnership with the Centre for Sexual Health and HIV/AIDS Research Zimbabwe, and is co-investigator of the HIV Modelling Consortium. In the past, she worked in designing and analyzing data from HIV observational studies (including the Royal Free HIV Cohort Study, PrEPaRe (Pre-Exposure Prophylaxis (PrEP) and Resistance) study within the RESPOND network and the PARTNER study, which led to the U=U initiative).

RELATED COURSES

CME Series | Implementation of HIV Prevention in Europe
HIV
60 min
Juan Ambrosioni, Àngel Rivero Calaf, Valentina Cambiano

CME Series | Implementation of HIV Prevention in Europe

This module examines the practical realities of implementing HIV prevention strategies across Europe, highlighting the key clinical, structural, and financial challenges. Through expert-led lectures, participants will explore considerations around efficacy, toxicity, and adherence, as well as the infrastructure and cost-related barriers to scaling up HIV prevention programs.

What Will Set You Apart?

By completing this module, you will:

  • Discuss key barriers and facilitators to implementing HIV prevention programs in Europe
  • Compare logistical and infrastructure challenges across different healthcare systems
  • Understand cost considerations for HIV prevention and their impact on access and public health outcomes

Is This Program for You?

This program is designed for healthcare providers, HIV program implementers, public health professionals, and policymakers engaged in HIV prevention across Europe. It is especially relevant for those working to overcome practical and systemic barriers to the delivery of effective and equitable prevention services.

What Will You Cover in This Module?

  • Efficacy, Toxicity, and Adherence Considerations
  • Logistical and Infrastructure Considerations
  • Price Considerations